These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26847280)

  • 1. Hemodynamic Follow-Up in Adult Patients with Pulmonary Hypertension Associated with Atrial Septal Defect after Partial Closure.
    Song J; Huh J; Lee SY; Kang IS; Lee CH; Lee C; Yang JH; Jun TG
    Yonsei Med J; 2016 Mar; 57(2):306-12. PubMed ID: 26847280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.
    D'Alto M; Romeo E; Argiento P; Correra A; Santoro G; Gaio G; Sarubbi B; Calabrò R; Russo MG
    Int J Cardiol; 2013 Oct; 168(4):3797-801. PubMed ID: 23850317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.
    Fujino T; Yao A; Hatano M; Inaba T; Muraoka H; Minatsuki S; Imamura T; Maki H; Kinugawa K; Ono M; Nagai R; Komuro I
    Int Heart J; 2015; 56(1):86-93. PubMed ID: 25742945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of preoperative oxygen saturation as a predictor of pulmonary arterial hypertension after surgery of atrial septal defects.
    Park HK; Shin HJ; Park YH; Ma BG
    Interact Cardiovasc Thorac Surg; 2016 Sep; 23(3):424-30. PubMed ID: 27222001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40 years.
    Wang JK; Chiu SN; Lin MT; Chen CA; Lu CW; Wu MH
    Heart Vessels; 2017 Apr; 32(4):467-473. PubMed ID: 27531005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of medical therapy for pulmonary hypertension and delayed atrial septal defect closure.
    Bradley EA; Chakinala M; Billadello JJ
    Am J Cardiol; 2013 Nov; 112(9):1471-6. PubMed ID: 23993122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter closure of secundum atrial septal defect in infants less than 12 months of age improves symptoms of chronic lung disease.
    Thomas VC; Vincent R; Raviele A; Diehl H; Qian H; Kim D
    Congenit Heart Dis; 2012; 7(3):204-11. PubMed ID: 21443579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension: hemodynamic outcomes.
    Talwar S; Keshri VK; Choudhary SK; Gupta SK; Ramakrishnan S; Saxena A; Kothari SS; Juneja R; Kumar G; Airan B
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2570-5. PubMed ID: 24332111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adults with congenital heart defects--clinical spectrum and surgical management].
    Berdjis F; Brandl D; Uhlemann F; Hausdorf G; Lange L; Weng Y; Loebe M; Alexi V; Hetzer R; Lange PE
    Herz; 1996 Oct; 21(5):330-6. PubMed ID: 9011542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance.
    Kannan BR; Sivasankaran S; Tharakan JA; Titus T; Ajith Kumar VK; Francis B; Krishnamoorthy KM; Harikrishnan S; Padmakumar R; Nair K
    Indian Heart J; 2003; 55(2):161-6. PubMed ID: 12921332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative changes of pulmonary artery pressure values and tricuspid valve regurgitation following transcatheter atrial septal defect closure in adults and the elderly.
    Yalonetsky S; Lorber A
    Congenit Heart Dis; 2009; 4(1):17-20. PubMed ID: 19207398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A different view on predictors of pulmonary hypertension in secundum atrial septal defect.
    Gabriels C; De Meester P; Pasquet A; De Backer J; Paelinck BP; Morissens M; Van De Bruaene A; Delcroix M; Budts W
    Int J Cardiol; 2014 Oct; 176(3):833-40. PubMed ID: 25149406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device closure of atrial septal defect with severe pulmonary hypertension in adults: Patient selection with early and intermediate term results.
    Dalvi B; Jain S; Pinto R
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):309-315. PubMed ID: 30346095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial septal defect-associated pulmonary hypertension with decompensated heart failure: outcomes after fenestrated device closure.
    Deniwar A; Hernandez J; Aregullin EO; Khan SK; Huang S; Finn MT; Vettukattil JJ
    Cardiol Young; 2024 Feb; 34(2):395-400. PubMed ID: 37466020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The short- and medium-term results of transcatheter closure of atrial septal defect with severe pulmonary arterial hypertension.
    Huang ZW; Fan ZX; Sun JT; Li WM; Gao YQ; Quan YH; Geng YM; Niu YY; Wu BX
    Heart Vessels; 2012 Nov; 27(6):603-9. PubMed ID: 21927863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenestrated Transcatheter ASD Closure in Adults with Diastolic Dysfunction and/or Pulmonary Hypertension: Case Series and Review of the Literature.
    Abdelkarim A; Levi DS; Tran B; Ghobrial J; Aboulhosn J
    Congenit Heart Dis; 2016 Dec; 11(6):663-671. PubMed ID: 27125263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study.
    Yong G; Khairy P; De Guise P; Dore A; Marcotte F; Mercier LA; Noble S; Ibrahim R
    Circ Cardiovasc Interv; 2009 Oct; 2(5):455-62. PubMed ID: 20031756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Pulmonary Hypertension in Adults After Atrial Septal Defect Closure.
    Zwijnenburg RD; Baggen VJM; Witsenburg M; Boersma E; Roos-Hesselink JW; van den Bosch AE
    Am J Cardiol; 2019 Apr; 123(8):1336-1342. PubMed ID: 30709596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.
    Takaya Y; Akagi T; Sakamoto I; Kanazawa H; Nakazawa G; Murakami T; Yao A; Nanasato M; Saji M; Hirokami M; Fuku Y; Hosokawa S; Tada N; Matsumoto K; Imai M; Nakagawa K; Ito H
    Heart; 2022 Mar; 108(5):382-387. PubMed ID: 34415851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects.
    Li Q; Dimopoulos K; Zhang C; Zhu Y; Liu Q; Gu H
    Pediatr Cardiol; 2018 Apr; 39(4):757-762. PubMed ID: 29426959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.